ImmunsanT announces end of its global Phase 2 clinical trial for its Nexvax2 drug candidate. Early results indicate gluten-exposure protection similar to placebo.
Continue ReadingAt the Digestive Disease Week meeting in San Diego, researchers from Takeda and the Celiac Disease Foundation presented a study entitled, Adherence to the gluten-free diet and celiac patients outcomes: real world evidences from an international patient registry, iCureCeliac®.
Continue ReadingIf you have celiac disease and currently have kidney stones, or have had kidney stones in the past, you may be eligible for a clinical research study!
Continue ReadingThere is significant overlap between NCGS and IBS. Gluten may not be the only culprit; other wheat compounds also play roles that might be the key to the difference in how NCGS and IBS are affected by eating wheat.
Continue ReadingThe Celiac Disease Foundation was proud to be a sponsor of the MedAboutData Hackathon in Haifa, Israel. During the hackathon, the ‘CeliACT’ team presented an innovative product that can assist in early detection of celiac disease.
Continue ReadingIf you have celiac disease and currently have kidney stones, or have had kidney stones in the past, you may be eligible for a clinical research study!
Continue ReadingResearchers analyzed iCureCeliac® patient registry data to determine the effect of celiac disease-related depression on patients’ symptomatic response to a gluten-free diet.
Continue ReadingAttention: Volunteers who have prior confirmation of celiac disease from blood work or a biopsy. If you meet the following criteria, you may qualify for a clinical research study of an investigational drug. Medical insurance is not necessary.
Continue ReadingThe CeliacShield Study is being conducted to assess the investigational drug latiglutenase and its ability to protect the small intestine of celiac disease patients from gluten exposure.
Continue ReadingResults from a new study suggest that cell immunity in the bowel is irreversibly altered by celiac disease. Early diagnosis and treatment of celiac disease may be able to save some of these beneficial cells and prevent additional permanent damage.
Continue ReadingCeliac Disease Foundation CEO Joins a Study Developing a Breakthrough Screening Tool The Celiac Disease Foundation asks patient families to participate in research every single day. Why? Because joining research studies and clinical trials is the only way to help scientists better understand this autoimmune disease and ultimately find a...